• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Control of immunological tolerance and its breakdown by cytokine

Research Project

Project/Area Number 14570277
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Immunology
Research InstitutionSHINSHU UNIVERSITY

Principal Investigator

TAKESHITA Toshikazu  Shinshu University School of Medicine, Microbiology and Immunology, Professor, 医学部, 教授 (60212023)

Co-Investigator(Kenkyū-buntansha) TANAKA Nobuyuki  Tohoku University Graduate School of Medicine, Associate Professor, 大学院・医学系研究科, 助教授 (60280872)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsIL-2 / signal transduction / MAPK / p38 / Mkk3 / Mkk6 / apoptosis / MAP kinase / STAM
Research Abstract

Interleukin-2 (IL-2), which was identified as T cell growth factor, plays a important role of the expansion and maintenance in immune response. IL-2-deficient-mice developed colonic inflamation closely resemblling ulcerative colitis in human. The inflamatory disease is characterized by high number of activated T and B cells and elevated immunoglobulin secretion, suggesting that the disease results from an abnormal immune response to a normal antigenic stimulus. On the other hand, immunosuppressive agents, which suppress the effects of IL-2, usually improve various autoimmune disorders. Therefore dysfunction or unusual activation in IL-2 signal transduction has influence on immunological tolerance directly. In this context, we have investigated the molecular machinery of the T cell growth and growth suppression by IL-2 to elucidate the basal mechanism of autoimmune disease. 1)we have established the screening system for the molecule(s) that involved in IL-2 signal transduction using the TPA-Mat, IL-2 and TPA dependent T cell line. 2)we found that the apoptosis of MT-1β resulted from AICD. 3) Although there was no significant difference in IL-2 dependent T cell proliferation among Mkk3^<-/->,Mkk6^<-/-> and wild type mice, the T cells from Mkk3^<-/-> mice were more resistant to apoptosis induced by IL-2 withdrawal. 4)The loss of Mkk3 and Mkk6 during embryogenesis was lethal before embryonic day E11.5. Major defects in the formation of the placenta, heart and deficiencies in the development of the embryonic vasculature were observed. Especially, the labyrinth and spongiotrophoblast layers were markedly decreased in the mutant compared with the wild type. TNF-α did not stimulate activation of p38 MAPK. UV radiation caused p38 MAPK activation in the cells from Mkk3^<-/-> and Mkk6^<-/-> mice, although the extent of p38 MAPK activation was diminished compared with wild-type cells.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (7 results)

All Other

All Publications (7 results)

  • [Publications] Brancho D., Tanaka N., et al.: "Mechanism of p38 MAP kinase activation in vivo."Genes Dev.. 17. 1969-1978 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tanaka N., et al.: "Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis."EMBO Rep.. 3. 785-791 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Brancho D., Tanaka N., Jaeschke A., Ventura J.-J., kelkar N., Tanaka Y., Kyuuma M., Takeshita T., Flavell A.R., Davis J.R.: "Mechanism of p38 MAP kinase activation in vivo."Genes Dev.. 17. 1969-1978 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Tanaka N., Kamanaka M., Enslen H., Dong C., Wysk M., Davis R.J., Flavell R.A.: "Differential involvement o p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis."EMBO Rep.. 3. 785-791 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Brancho, D., Tanaka N., et al.: "Mechanism of p38 MAP kinase activation in vivo"Genes Dev.. 17. 1969-1978 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Tanaka N., et al.: "Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis"EMBO Rep.. 3. 785-791 (2002)

    • Related Report
      2003 Annual Research Report
  • [Publications] Tamala N., et al.: "Differential involvement of p38 mitogen-activated protein kinase kinases MKK3 and MKK6 in T-cell apoptosis"EMBO Rep.. 3. 785-791 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi